Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaker A Mousa

Showing results (11-20 of 435) with videos related to

Pageof 44
Sort By:
Methods in Molecular Medicine|January 22, 2004
Highlights of latest advances in antithromboticsShaker A Mousa
Methods in Molecular Medicine|January 22, 2004
Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseasesShaker A Mousa
Current Pharmaceutical Design|October 8, 2003
Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyondShaker A Mousa
Current Opinion in Chemical Biology|July 23, 2002
Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implicationsShaker A Mousa
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 14, 2012
Comparative pharmacodynamic assessment of the antiangiogenesis activity of heparin and low-molecular-weight heparin fractions: structure-function relationshipShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Heparin and low-molecular weight heparins in thrombosis and beyondShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Novel anticoagulant therapy: principle and practiceShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Oral direct factor Xa inhibitors, with special emphasis on rivaroxabanShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Antiplatelet therapies: drug interactions in the management of vascular disordersShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Adhesion molecules: potential therapeutic and diagnostic implicationsShaker A Mousa
Pageof 44

Showing results (11-20 of 435) with videos related to

Sort By:
Pageof 44
Methods in Molecular Medicine|January 22, 2004
Highlights of latest advances in antithromboticsShaker A Mousa
Methods in Molecular Medicine|January 22, 2004
Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseasesShaker A Mousa
Current Pharmaceutical Design|October 8, 2003
Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyondShaker A Mousa
Current Opinion in Chemical Biology|July 23, 2002
Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implicationsShaker A Mousa
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 14, 2012
Comparative pharmacodynamic assessment of the antiangiogenesis activity of heparin and low-molecular-weight heparin fractions: structure-function relationshipShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Heparin and low-molecular weight heparins in thrombosis and beyondShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Novel anticoagulant therapy: principle and practiceShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Oral direct factor Xa inhibitors, with special emphasis on rivaroxabanShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Antiplatelet therapies: drug interactions in the management of vascular disordersShaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Adhesion molecules: potential therapeutic and diagnostic implicationsShaker A Mousa
Pageof 44